Abbisko Cayman Limited 2256.HK
2256.HK
Abbisko Cayman Limited 2142.HK
HBM Holdings Limited 2171.HK
CARsgen Therapeutics Holdings Limited 2616.HK
CStone Pharmaceuticals 2315.HK
Biocytogen Pharmaceuticals (Beijing) Co., Ltd. 6826.HK
Shanghai Haohai Biological Technology Co., Ltd. 9966.HK
Alphamab Oncology 6699.HK
Angelalign Technology Inc. 2157.HK
Lepu Biopharma Co., Ltd. 1672.HK
Ascletis Pharma Inc.
Abbisko Cayman Limited 2142.HK
HBM Holdings Limited 2171.HK
CARsgen Therapeutics Holdings Limited 2616.HK
CStone Pharmaceuticals 2315.HK
Biocytogen Pharmaceuticals (Beijing) Co., Ltd. 6826.HK
Shanghai Haohai Biological Technology Co., Ltd. 9966.HK
Alphamab Oncology 6699.HK
Angelalign Technology Inc. 2157.HK
Lepu Biopharma Co., Ltd. 1672.HK
Ascletis Pharma Inc.
Performance
| Periode | 2256.HK | 2142.HK | 2171.HK | 2616.HK | 2315.HK | 6826.HK | 9966.HK | 6699.HK | 2157.HK | 1672.HK |
|---|---|---|---|---|---|---|---|---|---|---|
| 6M | 128.95 % | 80.50 % | 35.48 % | 174.10 % | 101.69 % | 12.45 % | 104.68 % | 30.45 % | 65.66 % | 90.28 % |
| YTD | 255.10 % | 554.55 % | 84.01 % | 180.82 % | 186.75 % | 5.86 % | 295.63 % | 5.35 % | 160.32 % | 190.12 % |
| 1Y | 303.61 % | 920.47 % | 330.42 % | 282.22 % | 217.76 % | -19.47 % | 253.39 % | -0.97 % | 110.93 % | 596.30 % |
| 3Y | 436.30 % | 945.16 % | 30.17 % | 92.72 % | -8.46 % | 64.94 % | 129.61 % | -24.63 % | -11.35 % | 308.70 % |
| 5Y | 26.29 % | 17.60 % | -42.47 % | -43.61 % | -8.46 % | -19.61 % | -13.35 % | -84.78 % | -8.12 % | 208.20 % |
| 10Y | 26.29 % | 17.60 % | -42.47 % | -46.50 % | -8.46 % | -14.94 % | 0.52 % | -84.78 % | -8.12 % | -32.86 % |
| Depuis le début | 26.29 % | 17.60 % | -42.47 % | -46.50 % | -8.46 % | -35.03 % | 0.52 % | -84.78 % | -8.12 % | -32.86 % |